AbstractPurposeProgressive myoclonic epilepsy type one is a neurodegenerative disorder characterized by action- and stimulus-sensitive myoclonus, tonic–clonic seizures, progressive cerebellar ataxia, preserved cognition, and poor outcome. The authors report clinical, neurophysiological, radiological, and genetic findings of an Emirati family with five affected siblings and review the literature.MethodsAll data concerning familial and clinical history, neurologic examination, laboratory tests, electroencephalogram, brain imaging, and DNA analysis were examined.ResultsGenetic testing confirmed the diagnosis of autosomal recessive progressive myoclonic epilepsy type 1 (EPM1) in two males and three females. The median age at onset was three yea...
Background: The progressive myoclonic epilepsies (PME) are a heterogeneous group of disorders in whi...
This report illustrates the difficulties in diagnosing complex cases and demonstrates how whole exom...
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...
AbstractPurposeProgressive myoclonic epilepsy type one is a neurodegenerative disorder characterized...
Purpose: Progressive myoclonic epilepsy type one is a neurodegenerative disorder characterized by ac...
SummaryObjectiveMyoclonic epilepsy is a common epileptic syndrome with high genetic contribution. We...
Introduction: In 2011, a homozygous mutation in GOSR2 (c.430G > T; p. Gly144Trp) was reported as a n...
Progressive Myoclonus Epilepsies (PMEs) are a group of uncommon clinically and genetically heterogen...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
We describe two couples of sibs from a southern Italian family affected by epilepsy, myoclonus, ment...
Background: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characteri...
OBJECTIVE: Epilepsy with eyelid myoclonia (EEM) has been associated with marked clinical heterogenei...
AbstractIntroduction: Spinal muscular atrophies (SMAs) are a group of degenerative diseases primaril...
Progressive myoclonic epilepsy (PME) is a disease complex and is characterized by the development of...
Purpose: Progressive myoclonus epilepsies (PMEs) result from several genetic disorders. Few informat...
Background: The progressive myoclonic epilepsies (PME) are a heterogeneous group of disorders in whi...
This report illustrates the difficulties in diagnosing complex cases and demonstrates how whole exom...
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...
AbstractPurposeProgressive myoclonic epilepsy type one is a neurodegenerative disorder characterized...
Purpose: Progressive myoclonic epilepsy type one is a neurodegenerative disorder characterized by ac...
SummaryObjectiveMyoclonic epilepsy is a common epileptic syndrome with high genetic contribution. We...
Introduction: In 2011, a homozygous mutation in GOSR2 (c.430G > T; p. Gly144Trp) was reported as a n...
Progressive Myoclonus Epilepsies (PMEs) are a group of uncommon clinically and genetically heterogen...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
We describe two couples of sibs from a southern Italian family affected by epilepsy, myoclonus, ment...
Background: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characteri...
OBJECTIVE: Epilepsy with eyelid myoclonia (EEM) has been associated with marked clinical heterogenei...
AbstractIntroduction: Spinal muscular atrophies (SMAs) are a group of degenerative diseases primaril...
Progressive myoclonic epilepsy (PME) is a disease complex and is characterized by the development of...
Purpose: Progressive myoclonus epilepsies (PMEs) result from several genetic disorders. Few informat...
Background: The progressive myoclonic epilepsies (PME) are a heterogeneous group of disorders in whi...
This report illustrates the difficulties in diagnosing complex cases and demonstrates how whole exom...
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...